FDA Approves Lamictal(R)XR(TM) (Lamotrigine) for Conversion to Monotherapy for Treatment of Partial Seizures in Appropriate Patients

twitter.com/GSKUS or visit our blog ( www.morethanmedicine.us.gsk.com/blog/ ). *Depakene and Depakote are registered trademarks of Abbott Laboratories. Cautionary statement regarding forward-looking statements Under the safe harbor provisions of the U.S....